Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADIL | AMGN | BMY | GILD | VRTX |
| Company | Adial Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.1000 | 337.03 | 49.89 | 84.39 | 477.70 |
| High | 1.1000 | 338.70 | 50.04 | 84.65 | 482.00 |
| Low | 1.0600 | 334.61 | 49.11 | 83.57 | 476.27 |
| Last | 1.0795 | 336.78 | 49.26 | 84.36 | 480.23 |
| Change | -0.0005 | +3.86 | -0.48 | +0.47 | +6.07 |
| % Change | -0.05% | +1.16% | -0.97% | +0.56% | +1.28% |
| Volume | 148,657 | 510,446 | 2,442,931 | 2,766,352 | 282,078 |
| 20-Day Average Volume | 136,370 | 1,703,453 | 8,281,507 | 6,381,406 | 953,059 |
| Previous Close | 1.0800 | 332.92 | 49.74 | 83.89 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0326 | 329.59 | 49.11 | 80.09 | 479.92 |
| 20-Day Raw Stochastic | 70.59% | 85.03% | 63.91% | 93.45% | 46.46% |
| 20-Day Relative Strength | 51.64% | 57.71% | 55.71% | 72.57% | 49.97% |
| Weighted Alpha | -86.60 | +27.12 | -10.36 | +18.95 | +33.99 |
| Today's Opinion | 56% Sell | 96% Buy | 72% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 56% Sell | 88% Buy | 72% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 40% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.83% since 09/12/24 | +1.80% since 09/12/24 | +2.31% since 09/12/24 | +1.33% since 09/12/24 | +0.09% since 09/12/24 |
| Low | 1.0600 on 09/19/24 | 327.15 on 09/13/24 | 48.20 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 |
| High | 1.1200 on 09/17/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.61 on 09/19/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +9.18% since 08/19/24 | +2.45% since 08/19/24 | +0.11% since 08/19/24 | +13.18% since 08/19/24 | -1.84% since 08/19/24 |
| Low | 0.9500 on 08/30/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 |
| High | 1.1200 on 09/17/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | -15.75% since 06/18/24 | +9.81% since 06/18/24 | +20.94% since 06/18/24 | +33.44% since 06/18/24 | +2.52% since 06/18/24 |
| Low | 0.9000 on 08/05/24 | 303.55 on 06/20/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 |
| High | 3.0000 on 07/23/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -35.15% since 03/19/24 | +23.65% since 03/19/24 | -4.72% since 03/19/24 | +14.79% since 03/19/24 | +15.38% since 03/19/24 |
| Low | 0.9000 on 08/05/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 3.1000 on 04/15/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,572 | 178,589,936 | 100,827,960 | 104,514,608 | 122,358,416 |
| Shares Outstanding, K | 4,233 | 536,435 | 2,027,100 | 1,245,853 | 258,053 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -5,120,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -2,460,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.30 | 0.61 | 0.46 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 08/13/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/12/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 36.12 | 17.67 | 0.00 |